Cadrenal Therapeutics Inc
CVKD
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.23M
Close$
$2.01
52% downside
Current Fair Value
52% downsideOvervalued by 52% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.23 Million |
|---|---|
| Enterprise Value | $11.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.64 |
| Beta | 1.83 |
| Outstanding Shares | 2,407,665 |
Return
| Return on Equity | -318.55% |
|---|---|
| Return on Assets | -200.02% |
| Return on Invested Capital | -667.76% |
Valuation & Multiples
| P/E Ratio | -1 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.99 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-1.51
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-1.55
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.78%▼ 2.32% |
|---|---|
| Total Invested | $459,437▼ 44.22% |
| Investors Holding | 17▼ 1.00% |
ESG Score
No data